LYRA:NASDAQLyra Therapeutics, Inc. analysis
Data as of Oct 9, 2026 - not real-time
- Latest price
- $0.20
- Risk: high
- 9/10High risk
Summary
Lyra Therapeutics, Inc. is priced at $0.1950 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 22.0% over the past 30 days. Relative strength is 51.2 — neutral — and the MACD signal is bullish. The recent range runs from support at $0.0300 up to resistance at $0.2000.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 96.7%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 2099.6%, a beta of -5.12 and a maximum drawdown of 100.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 96.7%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 2099.6%, a beta of -5.12 and a maximum drawdown of 100.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.
Top market events
- Lyra Therapeutics stock reflects a biotech in transition as of September 20, 2026, with investors fo
- Lyra Therapeutics stock closed at a Nasdaq price dated September 22, 2026, while its latest reported
- Detailed price information for Lyra Therapeutics Inc LYRA from The Globe and Mail including charting and trades.
Market outlook
Short term
< 1 yearCautious
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.92
- MACD momentum is positive
Medium term
1–3 yearsCautious
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.92
- 30-day volatility of 2099.6%
Long term
> 3 yearsCautious
Model confidence5/105 out of 10
Key factors
- Negative return on equity of -6595.0%
- Revenue contracting at -96.7%
- Negative free cash flow
Key metrics
Financial health
Revenue Growth-96.70%
P/E Ratio-0.2
ROE-6594.98%
ROA-36.06%
P/B Ratio-0.0
Op. Cash Flow$-28859000
Free Cash Flow$-17529624
Industry P/E30.5
Technical analysis
TrendBearish
RSI51.2
Support$0.03
Resistance$0.20
MA 20$0.18
MA 50$0.20
MA 200$0.92
MACDBullish
VolumeStable
Fear & Greed Index94.93
Valuation
GradeFair
TypeBlend
Risk assessment
Beta-5.12
Volatility2099.62%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.